Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels.
about
Testosterone for the aging male; current evidence and recommended practiceThe benefits and risks of testosterone replacement therapy: a reviewDiscovery and therapeutic promise of selective androgen receptor modulatorsPreliminary development of a new individualised questionnaire measuring quality of life in older men with age-related hormonal decline: the A-RHDQoLTestosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practicesSex differences in the association between serum levels of testosterone and frailty in an elderly population: the Toledo Study for Healthy AgingThe FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates.Treatment with oxandrolone and the durability of effects in older men.Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis.Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?Muscle tissue changes with aging.Effect of Dehydroepiandrosterone and Testosterone Supplementation on Systemic Lipolysis.Causal relationship between obesity and serum testosterone status in men: A bi-directional mendelian randomization analysisEffect of standing posture during whole body vibration training on muscle morphology and function in older adults: a randomised controlled trial.Optimizing the benefits of exercise on physical function in older adults.Testosterone and Adipokines are Determinants of Physical Performance, Strength, and Aerobic Fitness in Frail, Obese, Older Adults.Testosterone and weight loss: the evidence.Testosterone supplementation therapy for older men: potential benefits and risks.Hormone treatment and muscle anabolism during aging: androgens.The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men.Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling.Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatmentEurycoma longifolia upregulates osteoprotegerin gene expression in androgen- deficient osteoporosis rat model.Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty.Andropause: clinical implications of the decline in serum testosterone levels with aging in men.Effects of testosterone therapy on muscle performance and physical function in older men with mobility limitations (The TOM Trial): design and methods.Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials.Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training.Effects of testosterone on lean mass gain in elderly men: systematic review with meta-analysis of controlled and randomized studies.Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine?Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan.Hormones and the aging process.Testosterone replacement alters the cell size in visceral fat but not in subcutaneous fat in hypogonadal aged male rats as a late-onset hypogonadism animal model.Late-onset hypogonadism syndrome and lower urinary tract symptoms.Androgen treatment and muscle strength in elderly men: A meta-analysis.Diagnosis and Treatment of Low Testosterone among Patients with End-Stage Renal Disease.The mechanisms of androgen effects on body composition: mesenchymal pluripotent cell as the target of androgen action.Regulation of body composition by androgens.Effects of androgen replacement on metabolism and physical performances in male hypogonadism.The effect of food composition on serum testosterone levels after oral administration of Andriol Testocaps.
P2860
Q24647679-CBE71094-B59B-40A6-9B7B-21BF0AAFFAE9Q24658011-6620EDA1-E7CA-451F-BCC8-2791C3CE4C74Q24680356-0AA4071B-E13B-40B5-B49E-25943967B230Q24791116-1C91A9A1-FDDD-45FA-95CD-D842C6F61D4CQ28295533-57B13783-045C-4A9D-A131-1D37B92C595CQ28731543-223F585B-F943-47A9-B978-10A0B5D3EFE3Q30576350-00E6B348-1D7E-421E-88EA-274DDFC3C05DQ30882835-F7080E20-5312-4AFA-BE09-441F01D43597Q33222142-BDD4219A-05B4-4835-8507-FECAFD2D35D4Q33569163-C6963204-37D8-4FFA-99CD-9F1343F0CBCBQ33584374-D31EE562-1BF3-421D-B74F-C17BD6D818C5Q33587927-2FAC246C-332A-453F-8F16-496C60B40E0EQ33610868-15BBA103-7F16-4EE5-9B60-9B99F99A4716Q33718743-45ED9910-2770-4783-B7AE-EAB5E6488CE9Q33779905-A8F16C03-8AF9-4FEA-A299-AF7ED24CC029Q34073323-A9518F78-08B0-4729-956B-35ABFA585FB9Q34134273-BEE4625D-3B3A-4113-99D8-92B96BC80B5AQ34171397-519EA9F7-1EC4-4908-8222-49125053F7FAQ34242584-DF9119AC-A21F-4345-A184-EEFD84505C47Q34276276-40E584F7-6CB4-45B8-8DE4-1FAB0418F2A7Q34384039-409DBF91-5FDA-44AD-AE1B-F158FCC6F58EQ34396808-6C247474-786F-4B4F-8047-E017840FAA99Q34411233-C6867AF3-92B7-439A-BFC6-9647B43BD645Q34458372-F6340E82-FCF6-40C7-962F-987A538504C0Q34511442-7EAD42BC-D43D-4145-BB6E-F9E7C536ACDDQ34540439-50048085-8FE9-4C8D-BF74-DFDB44E92334Q34676945-E10839EC-4BE0-40C6-A87B-95AB2D06E062Q34697114-37D9E119-BE45-4310-83F4-149DD8E77873Q35032969-47511088-B4AF-4858-BFC1-63F892109DA6Q35076387-7E6C9C10-700A-416F-B245-5B538A2AD1A4Q35117241-76D9DC24-A8CF-4775-A460-ACD6BFC12109Q35161374-72FABA3B-2F30-4FA7-9834-9CDF4FD45BCFQ35161777-5BB92115-B904-4356-91AC-34E4F75AA842Q35539874-F284B22F-1E85-4FE6-AD21-EFBB70E1B744Q35546738-66DD21B2-0885-4BEC-A816-B04CD197F1BDQ35576441-BE826E8F-8B29-493F-89EC-7EE6EE3EEFDDQ35611154-905FD39E-8E33-472B-9F2B-EDDE6C923D09Q35667540-CD589B3C-F1ED-45E4-9D66-E6D1032384F8Q35667571-108B43EC-90F4-43DB-911D-2BA7B44867ABQ35768803-B7E7AA82-4308-4573-AECB-7EBAB85B74E6
P2860
Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Effects of transdermal testost ...... available testosterone levels.
@ast
Effects of transdermal testost ...... available testosterone levels.
@en
type
label
Effects of transdermal testost ...... available testosterone levels.
@ast
Effects of transdermal testost ...... available testosterone levels.
@en
prefLabel
Effects of transdermal testost ...... available testosterone levels.
@ast
Effects of transdermal testost ...... available testosterone levels.
@en
P2093
P2860
P356
P1476
Effects of transdermal testost ...... available testosterone levels.
@en
P2093
P2860
P304
P356
10.1093/GERONA/56.5.M266
P407
P577
2001-05-01T00:00:00Z